GL1X · GenesisL1 explorer

Research workbench

Structure-based development of subtype-selective orexin 1 receptor antagonists

Analyse Structure-based development of subtype-selective orexin 1 receptor antagonists in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6V9S
Type
protein
Length
503 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Orexin receptor type 1,GLGA glycogen synthase chimera
UniProt
O43613, Q9V2J8
Ligands
JHC, CLR, OLA
Pockets
4 · best druggability 0.82

Structure

x-ray diffraction · 1 distinct chain · 65% helix, 8% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AOrexin receptor type 1,GLGA glycogen synthase chimeraprotein50365% helix, 8% strandO43613, Q9V2J8

Ligands and binding sites

  • JHC · [(2S)-2-[(2S)-butan-2-yl]-4-(5-chloro-1,3-benzoxazol-2-yl)-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone · ligand · chains A
  • CLR · Cholesterol · ligand · chains A
  • OLA · Oleic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110540.820.8376JHC
21680.470.7626empty
31200.450.7817empty
41810.450.7427empty

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 6V9S · Structure-based development of subtype-selective orexin 1 receptor antagonists · the same entry in another collection · chain A against A, TM-score 1.00
  • O43613 · AlphaFold monomer V2.0 prediction for orexin receptor type 1 (O43613) · a predicted model of the same protein · chain A against A, TM-score 0.61

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.